Ligand News and Research

RSS
Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

Tripep and Cosmix AG license RAS and mRNA Display Library technologies

Tripep and Cosmix AG license RAS and mRNA Display Library technologies

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Results of PCF funded study could impact the standard of care for prostate cancer patients

Results of PCF funded study could impact the standard of care for prostate cancer patients

Shape-changing in proteins opens new avenue for drug discovery

Shape-changing in proteins opens new avenue for drug discovery

CEL-SCI expands work on current H1N1 virus vaccine

CEL-SCI expands work on current H1N1 virus vaccine

Discovery of gene associated with a three-fold increase in risk for testicular cancer

Discovery of gene associated with a three-fold increase in risk for testicular cancer

Adult stem cells from bone marrow can deliver cancer-killing proteins to tumors

Adult stem cells from bone marrow can deliver cancer-killing proteins to tumors

Determining success or failure in cholesterol-controlling drugs

Determining success or failure in cholesterol-controlling drugs

Lymphocytes promote cancer spread

Lymphocytes promote cancer spread

A potential therapeutic target for gastric cancer

A potential therapeutic target for gastric cancer

Experimental insulin-like growth factor receptor inhibitor a clear clinical candidate for pancreatic cancer therapy

Experimental insulin-like growth factor receptor inhibitor a clear clinical candidate for pancreatic cancer therapy

Niacin findings could open up new avenues for drug discovery

Niacin findings could open up new avenues for drug discovery

Fluorescent anesthetic compound brings new avenues for drug discovery

Fluorescent anesthetic compound brings new avenues for drug discovery

Is telmisartan effective in treating non-alcoholic steatohepatitis?

Is telmisartan effective in treating non-alcoholic steatohepatitis?

FABLYN approved in Europe as osteoporosis treatment

FABLYN approved in Europe as osteoporosis treatment

Trial looks at telmisartan in treating non-alcoholic steatohepatitis

Trial looks at telmisartan in treating non-alcoholic steatohepatitis

Radioimmunotherapy shows promise for HIV infection and viral cancers

Radioimmunotherapy shows promise for HIV infection and viral cancers

Discovery of 'on switch' for cell death signaling mechanism

Discovery of 'on switch' for cell death signaling mechanism

What are protective effects of anti-ricin A-chain aptamer?

What are protective effects of anti-ricin A-chain aptamer?